161 related articles for article (PubMed ID: 37836742)
1. First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin.
Margariti A; Papakonstantinou VD; Stamatakis GM; Demopoulos CA; Machalia C; Emmanouilidou E; Schnakenburg G; Nika MC; Thomaidis NS; Philippopoulos AI
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836742
[TBL] [Abstract][Full Text] [Related]
2. Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(
Kalampalidis A; Damati A; Matthopoulos D; Tsoupras AB; Demopoulos CA; Schnakenburg G; Philippopoulos AI
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838847
[TBL] [Abstract][Full Text] [Related]
3. In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.
Tsoupras AB; Chini M; Tsogas N; Lioni A; Tsekes G; Demopoulos CA; Lazanas MC
J Inflamm (Lond); 2011 Jul; 8():17. PubMed ID: 21736752
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor levels and metabolism in Tangier disease: a case study.
Kolovou V; Papakonstantinou VD; Stamatakis G; Verouti SN; Xanthopoulou MN; Kolovou G; Demopoulos CA
Lipids Health Dis; 2012 Jul; 11():89. PubMed ID: 22769014
[TBL] [Abstract][Full Text] [Related]
6. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
[TBL] [Abstract][Full Text] [Related]
7. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration.
Moschos MM; Chatziralli IP; Stamatakis G; Papakonstantinou VD; Demopoulos CA
Cutan Ocul Toxicol; 2014 Sep; 33(3):235-41. PubMed ID: 24147947
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.
Korth R; Zimmermann K; Richter WO
Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283
[TBL] [Abstract][Full Text] [Related]
10. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and anti-thrombotic properties of lipid bioactives from the entomopathogenic fungus Beauveria bassiana.
Tsoupras A; Kouvelis VN; Pappas KM; Demopoulos CA; Typas MA
Prostaglandins Other Lipid Mediat; 2022 Feb; 158():106606. PubMed ID: 34923152
[TBL] [Abstract][Full Text] [Related]
13. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone.
Teng CM; Yu SM; Chen CC; Huang YL; Huang TF
Thromb Res; 1990 Jul; 59(1):121-30. PubMed ID: 2169076
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva.
Smal MA; Baldo BA
Platelets; 2022 May; 33(4):562-569. PubMed ID: 34348059
[TBL] [Abstract][Full Text] [Related]
17. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor and sheep platelets: a sensitive new bioassay.
Moon DG; van der Zee H; Morton KD; Krasodomski JA; Kaplan JE; Fenton JW
Thromb Res; 1990 Feb; 57(4):551-64. PubMed ID: 2326773
[TBL] [Abstract][Full Text] [Related]
20. Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factor.
Kaplanis M; Stamatakis G; Papakonstantinou VD; Paravatou-Petsotas M; Demopoulos CA; Mitsopoulou CA
J Inorg Biochem; 2014 Jun; 135():1-9. PubMed ID: 24632342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
